Early Phase 1 Obesity Trial, Recruiting (NCT07261475)

Early Phase 1 Obesity Trial, Recruiting NCT07261475 Sponsor: University of Primorska Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT07261475 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People with a body mass index (BMI) over 30 kg/m², which is classified as Class I obesity
People with prediabetes, meaning fasting blood sugar levels between 6.1 and 6.9 mmol/L

Who may not be able to join:

People with diseases affecting the digestive system or gut
People with any type of diabetes
People who are pregnant, breastfeeding, or not using contraception
People with serious health conditions such as cancer, severe infections, severe psychiatric disorders, autoimmune diseases, or inflammatory diseases
People who have taken part in another clinical trial within the 3 months before this study
People with a BMI greater than 35 kg/m²
People with coeliac disease or gluten intolerance
People who have an electronic implant (such as a pacemaker) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Nina Mohorko, PhD, University pf Primorska, Faculty of Health Sciences

Phone: +386 5 66 35 818

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07261475

Sponsor: University of Primorska

Phase: Early Phase 1

Status: Recruiting

Condition: Obesity

Trial contact: +386 5 66 35 818

More information: https://clinicaltrials.gov/study/NCT07261475

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People with a body mass index (BMI) over 30 kg/m², which is classified as Class I obesity
People with prediabetes, meaning fasting blood sugar levels between 6.1 and 6.9 mmol/L

Who may not be able to join:

People with diseases affecting the digestive system or gut
People with any type of diabetes
People who are pregnant, breastfeeding, or not using contraception
People with serious health conditions such as cancer, severe infections, severe psychiatric disorders, autoimmune diseases, or inflammatory diseases
People who have taken part in another clinical trial within the 3 months before this study
People with a BMI greater than 35 kg/m²
People with coeliac disease or gluten intolerance
People who have an electronic implant (such as a pacemaker) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

University of Primorska

Registry

ClinicalTrials.gov

Start date

6 February 2026

Est. completion

1 June 2026

Where this trial is recruiting

🇸🇮 Slovenia

Primary endpoints

glucose levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov